Novel pharmaceutical uses

• 收藏
• 分享

专利权人:

Takeda Pharmaceutical Company Limited

发明人:

Jenkins, Richard,Hibberd, Mark

申请号：

AU2016241069

公开号：

AU2016241069A1

申请日:

2016.03.30

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

The invention provides a potassium-competitive acid blocker (P-CAB) for use in the treatment, prevention and/or reduction of gastro-esophageal reflux disease (GERD) symptoms in patients who are partial responders to a proton pump inhibitor (PPI). The P-CAB may, for example, be selected from l-[5-(2-fluorophenyl)-l-(pyridin-3-ylsulfonyl)-lH-pyrrol-3-yl]-N- methylmethanamine (vonoprazan), revaprazan (YH1855), YH4808, RQ-4 and CS-526, or a salt thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/